trial · primary record
SIM0518
ALK-Positive or ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 270 |
| Primary completion | 2029-06-01 |
| Primary endpoint | Dose-limiting toxicity(DLT) (Dose escalation) |
| Registry ID | NCT07912268 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:44.769Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07912268
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.